| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Israel | 3 | |
| #2 | Australia | 2 | |
| #3 | Brazil | 1 | |
| #4 | Canada | 1 | |
| #5 | China | 1 | |
| #6 | EPO (European Patent Office) | 1 | |
| #7 | United States | 1 | |
| #8 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Basic materials chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Heterocyclic compounds | |
| #4 | Preservation of human bodies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Flynn Daniel L | 7 |
| #2 | Kaufman Michael D | 6 |
| #3 | Rosen Oliver | 5 |
| #4 | Smith Bryan D | 5 |
| #5 | Michael D Kaufman | 1 |
| #6 | Oliver Rosen | 1 |
| #7 | Daniel L Flynn | 1 |
| #8 | Petillo Peter A | 1 |
| #9 | Petrillo Peter A | 1 |
| #10 | Bryan D Smith | 1 |
| Publication | Filing date | Title |
|---|---|---|
| AU2017417160A1 | Use of 1-[4-bromo-5-[1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl]-2-fluorophenyl]-3-phenylurea and analogs for the treatment of cancers associated with genetic abnormalities in platelet derived growth factor receptor alpha |